Jan 26, 2023
Alleviant Medical Closes $75M in Financing; Receives FDA IDE Approval for Pivotal Clinical Trial
Read More
Dec 22, 2022
Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting
Read More
Dec 21, 2022
Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer
Read More
Dec 8, 2022
Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease
Read More
Dec 1, 2022
Rocket Pharmaceuticals Completes Acquisition of Renovacor
Read More
Nov 30, 2022
Broadview Ventures Appoints Cardiovascular Leader and Biotech Executive Michael Mendelsohn, MD to its Strategic Advisory Board
Read More
9101112131415